WHO Launches First Global Guideline on Balanced Access to Controlled Medicines
The World Health Organization (WHO) has released the full edition of its guideline on balanced national controlled medicines policies, the first comprehensive global framework aimed at ensuring access to controlled substances for medical and scientific purposes, while reducing the risks of misuse and diversion. This follows an initial rapid communication presented at the Seventy-eighth World Health Assembly, which introduced the guideline.
Controlled medicines such as opioids, benzodiazepines, barbiturates, and amphetamines are vital for pain relief, surgery, seizure management, palliative care, and the treatment of mental health and substance use disorders. Yet, millions of patients around the world remain unable to obtain them.
WHO estimates that up to 98% of patients in low-income...









